InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Michael Grosse, Président. Officer active across 1 company, notably Sartorius Stedim Biotech. Cumulatively, 1 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €158.3m. History available since 10 December 2025. The latest transaction was disclosed on 10 December 2025 (Cession). Regulator: AMF. The full history is free.
Companies and markets linked to Michael Grosse
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
750,000 股@ €211.10100.0% 占其流量ActionHors plateforme de négociationISIN FR00131540022025DD1074245
1 条申报中的 1 条
About Michael Grosse
Michael Grosse is the Chairman of Sartorius Stedim Biotech, a company specializing in solutions for the biopharmaceutical industry. As chairman, he oversees the company's activities and contributes to its growth strategy. Sartorius Stedim Biotech is recognized for its innovations in the biotechnology field.
